RARA CRAFT DATABASE for FDA Medical Devices
510(k)K152252

FDA DEVICE FACTS

Arthrex iBalance TKA System

Arthrex, Inc.

FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。

DECISION DATENovember 16, 2015PRODUCT CODEMBH

Indications for use

The Arthrex iBalance® TKA System is indicated for use in individuals undergoing surgery for:

• Painful, disabling joint disease of the knee resulting from degenerative arthritis, rheumatoid arthritis or post-traumatic arthritis;

• Post-traumatic loss of knee joint configuration and function

• Moderate varus, valgus, or flexion deformity in which the ligamentous structures can be returned to adequate function and stability;

• Revisions of previous unsuccessful knee replacement or other procedure. Additional indications for posteriorly stabilized components:

• Ligamentous instability requiring implant bearing surfaces with increased constraint;

• Absent or non-functioning posterior cruciate ligament. These devices are single use only and are intended for implantation with bone cement, with the exception of porous coated femoral components which can be used cemented or uncemented (biological fixation).

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: September 5, 2026